Background: Acne is a very common skin disorder in our society. Azithromycin, an oral macrolide, has been found to be a new treatment for this disease. Objective: To assess the efficacy and safety of alter-nate day oral azithromycin 500 mg in the treatment of mild to moderate acne vulgaris. Design: A quasi – experimental study. Place and Duration of Study: The study was con-ducted at the Department of Dermatology, Unit – I, KEMU / Mayo Hospital, Lahore, during the six mon-ths period from 11 th April to 10 t
To study the efficacy, safety, and compliance of 500 mg azithromycin thrice weekly for 8 weeks to tr...
This open, multicenter, comparative, randomized study included 120 subjects with papulopustular sta...
Background: Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit with considera...
The aim of the study was to investigate the efficacy, safety and compliance of 500 mg azithromycin t...
Introduction: Acne vulgaris is a chronic inflammatory dermatosis caused by Propionibacterium acnes. ...
AIM: To study the efficacy, safety, and compliance of 500 mg azithromycin thrice weekly for 12 weeks...
Background: Acne vulgaris is a chronic inflammatory skin disease that involves pilosebaceous units. ...
Acne vulgaris is the most common dermatological disorder in adolescence. As a matter of fact no ind...
Introduction: Oral azithromycin has been advocated by some in the treatment of acne. However, its ef...
Introduction: Oral azithromycin has been advocated by some in the treatment of acne. However, its ef...
Background: Acne vulgaris is a common skin disease seen primarily in adolescents and young adults. A...
Introduction: Acne vulgaris is the most common dermatological disorder in adolescence. Treatment is ...
BACKGROUND Azithromycin and doxycycline drugs are used orally in the treatment of acne vulgaris. T...
Acne vulgaris is a common inflammatory disorder of the skin. Oral antibiotics are known to be effect...
Acne vulgaris is a common deep inflammatory disease. Erythromycin and clindamycin topical solutions ...
To study the efficacy, safety, and compliance of 500 mg azithromycin thrice weekly for 8 weeks to tr...
This open, multicenter, comparative, randomized study included 120 subjects with papulopustular sta...
Background: Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit with considera...
The aim of the study was to investigate the efficacy, safety and compliance of 500 mg azithromycin t...
Introduction: Acne vulgaris is a chronic inflammatory dermatosis caused by Propionibacterium acnes. ...
AIM: To study the efficacy, safety, and compliance of 500 mg azithromycin thrice weekly for 12 weeks...
Background: Acne vulgaris is a chronic inflammatory skin disease that involves pilosebaceous units. ...
Acne vulgaris is the most common dermatological disorder in adolescence. As a matter of fact no ind...
Introduction: Oral azithromycin has been advocated by some in the treatment of acne. However, its ef...
Introduction: Oral azithromycin has been advocated by some in the treatment of acne. However, its ef...
Background: Acne vulgaris is a common skin disease seen primarily in adolescents and young adults. A...
Introduction: Acne vulgaris is the most common dermatological disorder in adolescence. Treatment is ...
BACKGROUND Azithromycin and doxycycline drugs are used orally in the treatment of acne vulgaris. T...
Acne vulgaris is a common inflammatory disorder of the skin. Oral antibiotics are known to be effect...
Acne vulgaris is a common deep inflammatory disease. Erythromycin and clindamycin topical solutions ...
To study the efficacy, safety, and compliance of 500 mg azithromycin thrice weekly for 8 weeks to tr...
This open, multicenter, comparative, randomized study included 120 subjects with papulopustular sta...
Background: Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit with considera...